Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000935836-24-000779·INOVIO PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
INOVIO PHARMACEUTICALS INC
Common Stock · CUSIP: 45773H409
Event date: 2024-12-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Stonepine Capital Management, LLC
Shares: 1,916,666.00 · Class: 5.2%
- Stonepine Capital, L.P.
Shares: 1,916,666.00 · Class: 5.2%
- Stonepine GP, LLC
Shares: 1,916,666.00 · Class: 5.2%
- Jon M. Plexico
Shares: 1,916,666.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-24-000779
- Form type
- SCHEDULE 13G
- Filer
- INOVIO PHARMACEUTICALS, INC.
- CIK
- CIK 1055726
- Filed
- Dec 23, 2024
- Reporting period
- Dec 17, 2024
- Description
- Schedule 13G beneficial ownership